TW200602316A - (Indol-3-yl)-heterocycle derivatives - Google Patents
(Indol-3-yl)-heterocycle derivativesInfo
- Publication number
- TW200602316A TW200602316A TW094105061A TW94105061A TW200602316A TW 200602316 A TW200602316 A TW 200602316A TW 094105061 A TW094105061 A TW 094105061A TW 94105061 A TW94105061 A TW 94105061A TW 200602316 A TW200602316 A TW 200602316A
- Authority
- TW
- Taiwan
- Prior art keywords
- alkyl
- alkyloxy
- halogen
- membered ring
- pain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04100902 | 2004-03-05 | ||
| EP04103901 | 2004-08-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200602316A true TW200602316A (en) | 2006-01-16 |
| TWI330635B TWI330635B (en) | 2010-09-21 |
Family
ID=36608981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094105061A TWI330635B (en) | 2004-03-05 | 2005-02-21 | (indol-3-yl)-heterocycle derivatives |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7700634B2 (zh) |
| EP (1) | EP1725232B1 (zh) |
| JP (1) | JP5011097B2 (zh) |
| AR (1) | AR048745A1 (zh) |
| AT (1) | ATE384525T1 (zh) |
| AU (1) | AU2005224041B2 (zh) |
| BR (1) | BRPI0508404A (zh) |
| CA (1) | CA2557054C (zh) |
| DE (1) | DE602005004515T2 (zh) |
| DK (1) | DK1725232T3 (zh) |
| ES (1) | ES2300995T3 (zh) |
| MY (1) | MY139070A (zh) |
| NZ (1) | NZ549386A (zh) |
| PE (1) | PE20060074A1 (zh) |
| PL (1) | PL1725232T3 (zh) |
| PT (1) | PT1725232E (zh) |
| RS (1) | RS20060502A (zh) |
| SI (1) | SI1725232T1 (zh) |
| TW (1) | TWI330635B (zh) |
| WO (1) | WO2005089754A1 (zh) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI330635B (en) | 2004-03-05 | 2010-09-21 | Organon Nv | (indol-3-yl)-heterocycle derivatives |
| TW200745096A (en) * | 2005-08-23 | 2007-12-16 | Organon Nv | Indole derivatives |
| US7763732B2 (en) | 2005-08-24 | 2010-07-27 | N.V. Organon | Indole derivatives |
| GB0614062D0 (en) * | 2006-07-14 | 2006-08-23 | Glaxo Group Ltd | Compounds |
| GB0614066D0 (en) * | 2006-07-14 | 2006-08-23 | Glaxo Group Ltd | Compounds |
| TW200848417A (en) * | 2007-02-22 | 2008-12-16 | Organon Nv | Indole derivatives |
| WO2022128050A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for fighting inflammation and pain |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ227841A (en) * | 1988-02-12 | 1991-08-27 | Merck Sharp & Dohme | Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions |
| US4939138A (en) | 1988-12-29 | 1990-07-03 | Sterling Drug Inc. | 2- and 3-aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo(1,2,3-DE)-1,4-benzoxazines |
| JP2004502642A (ja) * | 2000-02-11 | 2004-01-29 | ブリストル−マイヤーズ スクイブ カンパニー | カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用 |
| AUPR118000A0 (en) | 2000-11-02 | 2000-11-23 | Amrad Operations Pty. Limited | Therapeutic molecules and methods |
| ATE478670T1 (de) | 2001-01-29 | 2010-09-15 | Univ Connecticut | Rezeptor-selektive cannabimimetische aminoalkylindole |
| TW200402417A (en) * | 2002-06-21 | 2004-02-16 | Akzo Nobel Nv | 1-[(Indol-3-yl)carbonyl]piperazine derivatives |
| MXPA06006928A (es) | 2003-12-17 | 2006-09-04 | Akzo Nobel Nv | Derivados de 1-[(3-indol-3-il)carbonil] piperazina ciclica como agonistas del receptor canabinoide cb1. |
| TWI330635B (en) | 2004-03-05 | 2010-09-21 | Organon Nv | (indol-3-yl)-heterocycle derivatives |
| TW200745096A (en) | 2005-08-23 | 2007-12-16 | Organon Nv | Indole derivatives |
| US7763732B2 (en) * | 2005-08-24 | 2010-07-27 | N.V. Organon | Indole derivatives |
| TW200848417A (en) | 2007-02-22 | 2008-12-16 | Organon Nv | Indole derivatives |
-
2005
- 2005-02-21 TW TW094105061A patent/TWI330635B/zh not_active IP Right Cessation
- 2005-02-28 SI SI200530186T patent/SI1725232T1/sl unknown
- 2005-02-28 ES ES05716823T patent/ES2300995T3/es active Active
- 2005-02-28 PL PL05716823T patent/PL1725232T3/pl unknown
- 2005-02-28 AT AT05716823T patent/ATE384525T1/de active
- 2005-02-28 DK DK05716823T patent/DK1725232T3/da active
- 2005-02-28 WO PCT/EP2005/050833 patent/WO2005089754A1/en active IP Right Grant
- 2005-02-28 RS RSP-2006/0502A patent/RS20060502A/sr unknown
- 2005-02-28 JP JP2007501270A patent/JP5011097B2/ja not_active Expired - Fee Related
- 2005-02-28 BR BRPI0508404-0A patent/BRPI0508404A/pt not_active IP Right Cessation
- 2005-02-28 NZ NZ549386A patent/NZ549386A/en unknown
- 2005-02-28 EP EP05716823A patent/EP1725232B1/en active Active
- 2005-02-28 DE DE602005004515T patent/DE602005004515T2/de active Active
- 2005-02-28 CA CA2557054A patent/CA2557054C/en not_active Expired - Fee Related
- 2005-02-28 PT PT05716823T patent/PT1725232E/pt unknown
- 2005-02-28 US US10/590,674 patent/US7700634B2/en not_active Expired - Fee Related
- 2005-02-28 AU AU2005224041A patent/AU2005224041B2/en not_active Ceased
- 2005-03-02 MY MYPI20050850A patent/MY139070A/en unknown
- 2005-03-04 PE PE2005000245A patent/PE20060074A1/es not_active Application Discontinuation
- 2005-03-04 AR ARP050100825A patent/AR048745A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ549386A (en) | 2009-12-24 |
| BRPI0508404A (pt) | 2007-07-17 |
| CA2557054A1 (en) | 2005-09-29 |
| PL1725232T3 (pl) | 2008-07-31 |
| DE602005004515T2 (de) | 2009-01-29 |
| PE20060074A1 (es) | 2006-02-18 |
| WO2005089754A1 (en) | 2005-09-29 |
| TWI330635B (en) | 2010-09-21 |
| AU2005224041B2 (en) | 2011-03-10 |
| CA2557054C (en) | 2013-02-19 |
| PT1725232E (pt) | 2008-03-04 |
| DE602005004515D1 (de) | 2008-03-13 |
| US7700634B2 (en) | 2010-04-20 |
| SI1725232T1 (sl) | 2008-06-30 |
| RS20060502A (en) | 2008-11-28 |
| JP2007526281A (ja) | 2007-09-13 |
| ATE384525T1 (de) | 2008-02-15 |
| EP1725232A1 (en) | 2006-11-29 |
| AR048745A1 (es) | 2006-05-24 |
| EP1725232B1 (en) | 2008-01-23 |
| DK1725232T3 (da) | 2008-05-26 |
| ES2300995T3 (es) | 2008-06-16 |
| AU2005224041A1 (en) | 2005-09-29 |
| US20070142446A1 (en) | 2007-06-21 |
| JP5011097B2 (ja) | 2012-08-29 |
| MY139070A (en) | 2009-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200602316A (en) | (Indol-3-yl)-heterocycle derivatives | |
| PE20051095A1 (es) | DERIVADOS 1H-TIENO[2,3-c] PIRAZOL UTILES COMO INHIBIDORES DE QUINASA | |
| EA200501585A1 (ru) | Производные азетидинкарбоксамида и их применение при лечении нарушений, опосредованных св1 рецепторами | |
| TW200616953A (en) | Indole, indazole or indoline derivatives | |
| MY139941A (en) | Indole derivatives | |
| TW200800938A (en) | Indole carboxylic acid derivatives exhibiting PGD2 receptor antagonism | |
| BRPI0413233A (pt) | novos compostos | |
| CO6220908A2 (es) | Derivados de 2,3 -dihidroimizazo[1,2-c]quinazolina sustituidos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis | |
| MX2009006878A (es) | Derivados indolicos con anillo unido en las posiciones 4,5 para tratar o prevenir infecciones virales por virus de la hepatitis c e infecciones virales relacionadas. | |
| AR114354A2 (es) | Derivados de pirimidina | |
| EA200702058A1 (ru) | Новые фармацевтические соединения | |
| AR006906A1 (es) | Derivados de indazol sustituidos, composiciones farmaceuticas que los contienen, uso de los mismos e intermediarios de sintesis | |
| MXPA05007115A (es) | Nuevos agonistas inversos del receptor cb 1. | |
| CY1107677T1 (el) | Παραγωγα της 1-[indol-3-yl)carbonyl]piperazine | |
| HRP20060286T3 (en) | Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof | |
| ATE467632T1 (de) | Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors | |
| TW200745096A (en) | Indole derivatives | |
| MX2007004910A (es) | Nuevos derivados de indol o benzimidazol. | |
| MX2009008316A (es) | Derivados de indol. | |
| AU2003249484A1 (en) | Novel bio-active molecules | |
| MY157425A (en) | Substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses | |
| IL175675A0 (en) | Tricyclic 1-[(3-indol-3-yl)carbonyl] piperazine derivatives as cannabinoid cb1 receptor agonists | |
| UA83893C2 (ru) | Производные (индол-3-ил)гетероцикла как агонисты рецептора канабиноида cb1 | |
| DK1115404T3 (da) | Anvendelse af prostanoid-antagonister til bekæmpelse af primære hovedpiner | |
| NO20064063L (no) | (Indol-3-yl)-heterocykelderivater som agonister av kannabinoid CB1 reseptor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |